SAN FRANCISCO -- A new type of COVID-19 therapy is showing promise as a new tool to hijack the virus and slow down variants. It's a new weapon that could be added to the arsenal against COVID-19.

Kevin Whitehead, M.D., F.A.H.A. (SALT LAKE CITY) - Squirting a simple saline solution into the nose twice a day could alleviate chronic nosebleeds just as effectively as spraying with any one of three ...

For gene therapy to work well, therapeutic molecules need to be efficiently delivered to the correct locations in the body -- a job commonly given to adeno-associated viruses (AAV). To improve the AAV ...

Evoke Pharma submitted a new drug application to the FDA for its acute and recurrent diabetic gastroparesis nasal spray Gimoti. The spray relieves symptoms in adult women. 1. Acute and recurrent ...